Who
Vanina de Verneuil
EVP, General Counsel, Corp Sec
Company insider
Files Form 4 as: EVP, General Counsel, Corp Sec, Vir Biotechnology.
In numbers
- Trades disclosed
- 22
- Buys
- 0
- Sells
- 13
- Bought
- $0
- Sold
- $650K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Nov 2024
- Last trade
- 3 Nov 2026
- Last filed
- 4 Nov 2026
Companies traded
Activity over time
1 Dec 2024 – 1 Nov 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Nov 2026filed 4 Nov 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $27K2,407 at $11.10 | filing |
| 2 Nov 2026filed 4 Nov 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $15K1,343 at $11.33 | filing |
| 25 Feb 2026filed 26 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $135K13,700 at $9.82 | filing |
| 25 Feb 2026filed 26 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $135K13,700 at $9.82 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $30K3,117 at $9.53 | filing |
| 24 Feb 2026filed 26 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $30K3,117 at $9.53 | filing |
| 23 Feb 2026filed 24 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $33K4,445 at $7.45 | filing |
| 23 Feb 2026filed 24 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $33K4,445 at $7.45 | filing |
| 22 Feb 2026filed 24 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 22 Feb 2026filed 24 Feb 2026 | VIR Vir Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 22 Feb 2026filed 24 Feb 2026 | VIR Vir Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 22 Feb 2026filed 24 Feb 2026 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 5 Nov 2025filed 7 Nov 2025 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $12K2,385 at $5.16 | filing |
| 3 Nov 2025filed 4 Nov 2025 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $7,9991,365 at $5.86 | filing |
| 26 Feb 2025filed 27 Feb 2025 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $67K7,373 at $9.14 | filing |
| 24 Feb 2025filed 25 Feb 2025 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $49K5,140 at $9.45 | filing |
| 22 Feb 2025filed 25 Feb 2025 | VIR Vir Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 22 Feb 2025filed 25 Feb 2025 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 2 Dec 2024filed 4 Dec 2024 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $62576 at $8.22 | filing |
| 6 Nov 2024filed 7 Nov 2024 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Sold | $44K4,397 at $10.11 | filing |
News
Vir Biotechnology (NASDAQ:VIR) EVP Sells 2,407 Shares of StockVIR · themarketsdaily.com · 4 Nov 2026
0 headlines in the last 90 days name Vanina de Verneuil; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.